| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/17/2007 | EP1370259B1 Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder |
| 01/17/2007 | EP1345501B1 Nutritional and therapeutical preparations having antioxidant activity |
| 01/17/2007 | EP1337233B1 Use of at least a sulphonic amino derivative in a composition promoting skin peeling |
| 01/17/2007 | EP1322411B1 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1170013B1 Drugs, foods, drinks and feeds containing cocoa component |
| 01/17/2007 | EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 01/17/2007 | EP1086207B1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 01/17/2007 | CN1898370A Fat composition |
| 01/17/2007 | CN1897973A Propagation agent and propagation method for natural killer cell |
| 01/17/2007 | CN1897972A Agents for treatment of glaucomatous retinopathy and optic neuropathy |
| 01/17/2007 | CN1897957A Chaperone-based therapy for niemann-pick disease |
| 01/17/2007 | CN1897949A Combination therapy comprising the use of et-743 and paclitaxel for treating cancer |
| 01/17/2007 | CN1897890A Use of alginate matrices to control cell growth |
| 01/17/2007 | CN1896270A Therapeutic and preventing methods for bone loss |
| 01/17/2007 | CN1896045A Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 01/17/2007 | CN1895674A Medicinal composition containing sulfourea antidiabetic medicine and vitamine B |
| 01/17/2007 | CN1895673A The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 01/17/2007 | CN1895672A Multifunctional broad-spectrum obtundent of polyphyletic synergistic and its use |
| 01/17/2007 | CN1895671A Compound preparation for treating viral liver disease |
| 01/17/2007 | CN1895660A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 01/17/2007 | CN1895287A Medicine with antibacterial, antiviral, anticancer, antineoplastic, antianaphylaxis and anti-deficit functions |
| 01/17/2007 | CN1295242C 3'-prodrugs of 2'-deoxy-beta-L-nucleosides |
| 01/17/2007 | CN1294993C Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| 01/17/2007 | CN1294896C Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same |
| 01/16/2007 | US7164034 treating a disorder selected from obsessive compulsive disorder (OCD), agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, post traumatic stress syndrome (PTSD), restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/16/2007 | US7164000 RANTES mutants and therapeutic applications thereof |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/16/2007 | US7163952 Azole compound and medicinal use thereof |
| 01/16/2007 | US7163930 Pharmaceutical compositions and methods relating to fucans |
| 01/16/2007 | US7163808 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 01/16/2007 | US7163703 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/16/2007 | US7163698 Complex of drug and polyester |
| 01/16/2007 | US7163686 Protein A based binding domains with desirable activities |
| 01/16/2007 | US7163681 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 01/16/2007 | US7162976 Method for reducing bacterial contamination and infectious diseases in livestock and other animals |
| 01/16/2007 | CA2401492C Method for making, loading and sealing a cell or drug encapsulation device, and such a device |
| 01/16/2007 | CA2294196C Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery |
| 01/16/2007 | CA2281473C Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
| 01/16/2007 | CA2174449C R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 01/11/2007 | WO2007005763A2 Combination of a renin inhibitor and an insulin secretion enhancer or an insulin sensitizer |
| 01/11/2007 | WO2007005760A1 Methods of application of chemical compounds having therapeutic activities in treating cancers |
| 01/11/2007 | WO2007004685A2 Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions |
| 01/11/2007 | WO2007004510A1 Pharmaceutical for use in the treatment of cerebral infarction |
| 01/11/2007 | WO2007004337A1 White hair development model animal, method for establishing white hair development model animal, method for passage of white hair development model animal, method for study on white hair development, screening method for white hair development-control means, and composition for control of white hair development |
| 01/11/2007 | WO2007004244A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
| 01/11/2007 | WO2007003554A1 Novel medicinal combinations which are used for treating respiratory tract diseases and contain beta-2 long-acting agonists and at least one other type of active substance. |
| 01/11/2007 | WO2007003020A1 Oral formulations comprising ondansetron and a highly dosed sweeten |
| 01/11/2007 | WO2006113151A3 Use of an epidermal growth factor receptor kinase inhibitor (egfr) in gefitinib resistant patients |
| 01/11/2007 | WO2005025620A3 Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents |
| 01/11/2007 | US20070010574 Use of a trpm8-activating substance for the treatment of tumours |
| 01/11/2007 | US20070010502 Synergistic mixture containing pyrimidopyrimidine compound with another active material |
| 01/11/2007 | US20070010499 Medicinal compositions containing aspirin |
| 01/11/2007 | US20070010497 Pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine |
| 01/11/2007 | US20070010483 Glucocerebroside treatment of liver disorders |
| 01/11/2007 | US20070010476 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 01/11/2007 | US20070010448 Drug targets in Candida albicans |
| 01/11/2007 | US20070010434 Novel compositions and methods for the treatment of immune related diseases |
| 01/11/2007 | US20070010432 Heat shock protein 90 activator |
| 01/11/2007 | US20070010423 Compositions comprising balaglitazone and further antidiabetic compounds |
| 01/11/2007 | US20070010030 Complement C3 precursor biopolymer markers indicative of insulin resistance |
| 01/11/2007 | US20070009963 Apolipoprotein biopolymer marker indicative of normal human |
| 01/11/2007 | US20070009946 Retrieving ductal fluid samples from ducts using elongated lumen and detecting presence of papilloma, Epstein-barr and herpes virus |
| 01/11/2007 | US20070009933 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 01/11/2007 | US20070009611 Treatment of wounds and compositions employed |
| 01/11/2007 | US20070009603 Compositions comprising fenofibrate and atorvastatin |
| 01/11/2007 | US20070009601 Composition and method for the treatment of water related ear disorders |
| 01/11/2007 | US20070009597 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 01/11/2007 | US20070009593 Methods of treating cancer |
| 01/11/2007 | US20070009576 Nutritionally fortified liquid composition with added value delivery systems/elements/additives |
| 01/11/2007 | US20070009546 Isolated nucleic acid; screening for antibacterial compounds |
| 01/11/2007 | US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 01/11/2007 | US20070009519 Immunoregulatory Antibodies and Uses Thereof |
| 01/11/2007 | US20070009517 Method of inducing immune tolerance |
| 01/11/2007 | US20070009488 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules |
| 01/11/2007 | US20070009451 Cosmetic and/or pharmaceutical compositions for the cure and prevention of irritation, inflammation and cutaneous erythema |
| 01/11/2007 | DE102005031780A1 Use of aromatase inhibitor for treatment and/or prevention of cancers, e.g. breast cancer and its metastases |
| 01/11/2007 | DE102005031736A1 Combined preparation, useful for improving process of cell renewal, regulating water content and promoting osmosis in the body, contains major and minor elements and vitamins |
| 01/11/2007 | DE102005030614A1 Zellfreies Transplantat Cell-free graft |
| 01/11/2007 | CA2613828A1 Novel medicinal combinations which are used for treating respiratory tract diseases and contain beta-2 long-acting agonists and at least one other type of active substance. |
| 01/11/2007 | CA2613627A1 Kinin antagonists for treating bladder dysfunction |
| 01/11/2007 | CA2613585A1 Combination of a renin inhibitor and an insulin secretion enhancer or an insulin sensitizer |
| 01/11/2007 | CA2613343A1 Compositions comprising arachidonic acid and docosapentaenoic acid for ameliorating reduced higher brain functions resyktubg from organic brain lesions |
| 01/10/2007 | EP1741792A1 Novel ligand of g-protein-conjugated receptor protein and use thereof |
| 01/10/2007 | EP1741779A2 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity |
| 01/10/2007 | EP1741722A2 Polymorphisms in the human P2X7 gene |
| 01/10/2007 | EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 01/10/2007 | EP1741697A1 Crystal comprising (2r)-2-propyloctoic acid and amine |
| 01/10/2007 | EP1741447A2 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/10/2007 | EP1741446A2 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/10/2007 | EP1741445A2 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/10/2007 | EP1741444A1 Kinin antagonists for treating bladder dysfunction |
| 01/10/2007 | EP1741441A1 Bone densifying agent characterized by use of cathepsin k inhibitor with pth |
| 01/10/2007 | EP1741439A1 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method |
| 01/10/2007 | EP1741436A1 Strontium compound for treatment of sub-dermal soft tissue pain |
| 01/10/2007 | EP1741431A1 The combination for treating hyperlipemia |
| 01/10/2007 | EP1741425A2 Novel antiviral pharmaceutical composition |
| 01/10/2007 | EP1740946A2 Human monoclonal antibodies against cd20 |
| 01/10/2007 | EP1740549A2 Novel imidazoles |